The Rising Influence of Rising Affluence

[DewDiligence]

Factoid—$290B of worldwide branded-drug sales are going off-patent between now and the end of 2018, according to EvaluatePharma:

http://finance.yahoo.com/news/patent-expirations-put-more-290-100000108.html

According to the same firm, worldwide sales of patented branded drugs—a classification that excludes branded generics—will grow at a measly average annual rate of 3% per year (not adjusted for inflation) to $885B in 2018.

The ramifications are obvious: branded generics in emerging markets are the future growth engine of the pharma industry. For related info, please see #msg-61960541 (and the 30+ replies to that post), #msg-63363435, and #msg-66847069. For additional color on specific countries, see #msg-66551481, #msg-50473238, and #msg-39315651.